EPCAM and neoplasm: While EpCAM expression on most carcinoma is a highly attractive feature for tumor-associated antigens, expression on healthy epithelia—mostly of the gastrointestinal tract—will limit the therapeutic window of EpCAM-targeted therapies and call for potential side effects.